trending Market Intelligence /marketintelligence/en/news-insights/trending/5TkrLE8d-7h0gvVEzxGQsA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

S&P upgrades Vizient's rating on successful integration of new segments

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

S&P upgrades Vizient's rating on successful integration of new segments

S&P Global Ratings upgraded Vizient Inc.'s corporate credit rating to B+ from B.

The outlook is stable.

S&P said the upgrade takes into account the company's largely complete integration of competitor MedAssets Inc.'s group purchasing organization and analytics and consulting business.

Vizient acquired MedAssets' Spend and Clinical Management segment in early 2016. S&P said leverage is trending lower than expected, adding that it expects acquisition and integration charges will be modest and the company will start generating moderate discretionary cash flow.

The rating agency also believes the deal has reduced the company's appetite for acquisitions and expects acquisition activity to be limited to tuck-in acquisitions.

S&P said the stable outlook reflects its expectation that Vizient will limit acquisition activity to tuck-in acquisitions, its restructuring and integration charges will be modest and it will begin generating moderate free cash flow, resulting in a decline in leverage.

S&P Global Ratings and S&P Global Market Intelligence are owned by S&P Global Inc.